Cowen Reiterates Market Perform Rating on Pacira Pharmaceuticals (PCRX), Announces $43 PT
Tweet Send to a Friend
Cowen analyst Boris Peaker reiterated a Market Perform rating and $43.00 price target on Pacira Pharmaceuticals (NASDAQ: PCRX).The analyst introduces ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
